Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Clinically confirmed Birt-Hogg-Dube (BHD) syndrome
- Specific FLCN mutations include c.1285dupC (p.His429ProfsX27), c.715C>T (p.Arg239Cys), c.764A>C (p.His255Pro), and c.610_611delGCinsTA (p.Ala204X).
- Patients without above FLCN mutations.